Literature DB >> 11402034

Mapping the functional domains of HAP95, a protein that binds RNA helicase A and activates the constitutive transport element of type D retroviruses.

J P Yang1, H Tang, T R Reddy, F Wong-Staal.   

Abstract

The complex retroviruses such as human immunodeficiency virus, type 1, employ a virally encoded protein, Rev, to mediate the nuclear export of unspliced and partially spliced mRNA. In contrast, the simian type D retroviruses act through a cis-acting constitutive transport element (CTE) that presumably interacts directly with cellular export proteins. We first reported that RNA helicase A (RHA) is a shuttle protein that binds to functional CTE in vitro and in vivo. Recently, we isolated a novel protein, HAP95, that specifically binds to the nuclear transport domain of RHA and up-regulates CTE-mediated gene expression. Here, using truncation and deletion mutations, we mapped the domains of HAP95 that are important for RHA binding, transactivation of CTE, and nuclear cytoplasmic shuttling. We report evidence for a novel nuclear export signal in HAP95 and showed that the domains involved in RHA binding and nuclear localization are required for CTE activation. Finally, we showed that HAP95 synergizes significantly with RHA on CTE-mediated reporter gene expression and promotes nuclear export of unspliced mRNA in transfected cells. Taken together, these data support the proposal that HAP95 specifically facilitates CTE-mediated gene expression by directly binding to RHA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402034     DOI: 10.1074/jbc.M102809200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.

Authors:  Jonathan A Sayer; Maria Manczak; Lakshmi Akileswaran; P Hemachandra Reddy; Vincent M Coghlan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.

Authors:  Wenmin Fu; Dinesh Verma; Ashlee Burton; Sankar Swaminathan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.

Authors:  Innoc Han; Yong Xue; Shizuko Harada; Sigurd Orstavik; Bjorn Skalhegg; Elliott Kieff
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  A-kinase anchoring protein 8L interacts with mTORC1 and promotes cell growth.

Authors:  Chase H Melick; Delong Meng; Jenna L Jewell
Journal:  J Biol Chem       Date:  2020-04-20       Impact factor: 5.157

5.  Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.

Authors:  D Portal; A Rosendorff; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-11       Impact factor: 11.205

6.  RNA helicase A interacts with dsDNA and topoisomerase IIalpha.

Authors:  Kai Zhou; Kyoo-Tae Choe; Zaheer Zaidi; Qi Wang; Michael B Mathews; Chee-Gun Lee
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

7.  Regulation of the catalytic function of topoisomerase II alpha through association with RNA.

Authors:  Seung-Won Park; Andrew M Parrott; David T Fritz; Yongkyu Park; Michael B Mathews; Chee-Gun Lee
Journal:  Nucleic Acids Res       Date:  2008-09-27       Impact factor: 16.971

8.  HA95 and LAP2 beta mediate a novel chromatin-nuclear envelope interaction implicated in initiation of DNA replication.

Authors:  Sandra Martins; Sissel Eikvar; Kazuhiro Furukawa; Philippe Collas
Journal:  J Cell Biol       Date:  2003-01-21       Impact factor: 10.539

9.  The role of A-kinase anchoring protein 95-like protein in annealing of tRNALys3 to HIV-1 RNA.

Authors:  Li Xing; Xia Zhao; Fei Guo; Lawrence Kleiman
Journal:  Retrovirology       Date:  2014-07-17       Impact factor: 4.602

Review 10.  The biology of DHX9 and its potential as a therapeutic target.

Authors:  Teresa Lee; Jerry Pelletier
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.